Since its inception, Lemhi Ventures has successfully exited eight portfolio companies.
In January 2010, DNA Direct was acquired by Medco Health Solutions, Inc. DNA Direct tracked evidence-based, peer-reviewed literature to validate the clinical utility and medical actionability of new genetics tests. With this information, the company pioneered the delivery of online genetics information to individuals.
In April 2011, Liazon Corporation secured funding from an investor group led by Bain Capital Ventures that enabled the company to repurchase Lemhi’s holdings. Liazon provided a consumer-driven, defined contribution funding strategy for all types of benefits. The tools enable employers to predict and control benefits costs.
In November 2011, Carol was acquired by OptumHealth. Carol worked with providers, health plans, and employers to develop a value-based payment system. The company’s consulting services, products, and technology enabled providers and insurers to quantify, capture, and report on the actuarial value associated with care delivery and payment processing.
In January 2013, DestinationRx (DRX) was acquired by Connecture, Inc. DestinationRx was a pioneer developer of drug comparison and purchasing tools for government, health plans, pharmacy benefit managers (PBMs), and consumers.
ABILITY Network, Inc.
In June 2014, ABILITY Network, Inc. was acquired by Summit Partners. ABILITY Network (founded as VisionShare) connected hospitals, clinics, skilled nursing facilities, physicians, and other health care providers across the country with the nation’s largest payer, the Centers for Medicare and Medicaid Services.
OneHealth Solutions, Inc.
In September 2014, OneHealth Solutions, Inc. (founded as OneRecovery, Inc.) was acquired by Viverae. OneHealth Solutions developed a novel form of disease, care, and case management utilizing an anonymous, secure, and clinically supported social networking platform.
In February 2014, the assets of TransEngen, Inc. were acquired by VirMedica, Inc., with financing from Petra Capital Partners and HealthQuest Capital. TransEngen developed an intelligent transaction processing engine providing end-to-end connectivity between payers, providers, and consumers.
In January 2016, Shareable (formerly Shareable Ink) was acquired by Digital Reasoning, a leader in cognitive computing technology. Shareable Ink developed a mobile clinical documentation platform to convert handwriting and other natural inputs into codified, structured data.